Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -1655.35% is in line with its 5-year average of -1707.03%, near the high end of its 5-year range (-5906.90%–-271.99%).
11.25% above its 12-month average of -1865.25%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2888.58%.
NET PROFIT MARGIN
-1655.35%
NET PROFIT MARGIN AVG TTM
-1865.25%
NET PROFIT MARGIN AVG 3Y
-2460.92%
NET PROFIT MARGIN AVG 5Y
-1707.03%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+11.25%
CURRENT VS 3Y AVG
+32.73%
CURRENT VS 5Y AVG
+3.03%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-472857.14%
vs the sector median at left
TScan Therapeutics, Inc.
Market Cap
$16.82M
Net Profit Margin
-1655.35%
TTM Avg
-1865.25%
3Y Avg
-2460.92%
5Y Avg
-1707.03%
Market Cap
$16.84M
Net Profit Margin
-706.23%
TTM Avg
-81.41%
3Y Avg
-315.86%
5Y Avg
-1797.64%
Market Cap
$16.74M
Net Profit Margin
-63.54%
TTM Avg
-31.77%
3Y Avg
-305.26%
5Y Avg
2352.19%
Market Cap
$16.64M
Net Profit Margin
-106.58%
TTM Avg
-228.29%
3Y Avg
-394.31%
5Y Avg
-410.59%
Market Cap
$17.07M
Net Profit Margin
-10794.64%
TTM Avg
946.68%
3Y Avg
-6081.70%
5Y Avg
-5732.70%
Market Cap
$16.52M
Net Profit Margin
-219.50%
TTM Avg
-381.91%
3Y Avg
-332.62%
5Y Avg
-409.39%
Market Cap
$17.31M
Net Profit Margin
-755.13%
TTM Avg
-243.50%
3Y Avg
-516.28%
5Y Avg
-344.84%
Market Cap
$17.39M
Net Profit Margin
-33.08%
TTM Avg
-29.53%
3Y Avg
-30.32%
5Y Avg
-22.32%
Market Cap
$15.78M
Net Profit Margin
0.00%
TTM Avg
-6850.00%
3Y Avg
-4251.62%
5Y Avg
-4766.26%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TScan Therapeutics, Inc. (TCRX) | $16.82M | -1655.35% | -1865.25% | -2460.92% | -1707.03% |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | -706.23% | -81.41% | -315.86% | -1797.64% |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | -63.54% | -31.77% | -305.26% | 2352.19% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | -106.58% | -228.29% | -394.31% | -410.59% |
| PAVmed Inc. (PAVM)vs › | $17.07M | -10794.64% | 946.68% | -6081.70% | -5732.70% |
| Dyadic International, Inc. (DYAI)vs › | $16.52M | -219.50% | -381.91% | -332.62% | -409.39% |
| Lipocine Inc. (LPCN)vs › | $17.31M | -755.13% | -243.50% | -516.28% | -344.84% |
| Cosmos Health Inc. (COSM)vs › | $17.39M | -33.08% | -29.53% | -30.32% | -22.32% |
| BioCardia, Inc. (BCDA)vs › | $15.78M | 0.00% | -6850.00% | -4251.62% | -4766.26% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.68M | -3575.07% | -1754.85% | -877.42% | -584.95% |
Operating Margin
-1315.4%
Net Profit Margin
-1655.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -2888.58% |
| 2026-03-31 | -2919.14% |
| 2025-12-31 | -895.09% |
| 2025-09-30 | -1422.14% |
| 2025-06-30 | -1201.30% |
| 2025-03-31 | -1571.95% |
| 2024-12-31 | -5384.81% |
| 2024-09-30 | -2849.09% |
| 2024-06-30 | -5906.90% |
| 2024-03-31 | -5325.44% |
| 2023-12-31 | -271.99% |
| 2023-09-30 | -591.64% |
| 2023-06-30 | -763.82% |
| 2023-03-31 | -331.66% |
| 2022-12-31 | -604.94% |
| 2022-09-30 | -483.05% |
| 2022-06-30 | -372.21% |
| 2022-03-31 | -534.79% |
| 2021-12-31 | -497.55% |
| 2021-09-30 | -656.67% |
| 2021-06-30 | -374.79% |
| 2021-03-31 | -390.33% |
| 2020-12-31 | -982.01% |
| 2020-09-30 | -2472.41% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
